VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
VYOME HOLDINGS, INC. (HIND) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $3455.91 per share as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2025-11-14
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3455.91.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $3451.03.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $25.47.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $40.31.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2025-09-30 | $3455.91 10-Q · filed 2025-11-14 |
| 2024-12-31 | $3451.03 10-Q · filed 2025-11-14 |
| 2021-03-31 | $25.47 10-Q · filed 2021-05-12 |
| 2020-12-31 | $40.31 10-K · filed 2021-03-12 |
| 2020-09-30 | $41.48 10-Q · filed 2020-11-06 |
| 2020-06-30 | $46.65 10-Q · filed 2020-07-30 |
| 2020-03-31 | $48.71 10-Q · filed 2020-06-19 |
| 2019-12-31 | $52.72 10-K · filed 2020-02-27 |
| 2019-09-30 | $52.52 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.29 10-Q · filed 2019-07-24 |
| 2019-03-31 | $6.02 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.99 10-K · filed 2019-02-22 |
| 2018-09-30 | $5.93 10-Q · filed 2018-11-02 |
| 2018-06-30 | $5.73 10-Q · filed 2018-08-02 |
| 2018-03-31 | $4.70 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.36 10-K · filed 2018-03-05 |
| 2017-09-30 | $3.95 10-Q · filed 2017-11-03 |
| 2017-06-30 | $3.40 10-Q · filed 2017-08-02 |
| 2017-03-31 | $2.67 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.92 10-K · filed 2017-02-23 |
| 2016-09-30 | $1.76 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |